Compare IAM & DMII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IAM | DMII |
|---|---|---|
| Founded | 2019 | 2024 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 683.0M | 649.1M |
| IPO Year | 2026 | 2025 |
| Metric | IAM | DMII |
|---|---|---|
| Price | $15.48 | $10.24 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $24.67 | N/A |
| AVG Volume (30 Days) | ★ 648.2K | 184.2K |
| Earning Date | 11-23-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $225.80 | N/A |
| Revenue Next Year | $150.81 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.60 | $9.87 |
| 52 Week High | $24.49 | $10.33 |
| Indicator | IAM | DMII |
|---|---|---|
| Relative Strength Index (RSI) | 33.63 | 73.78 |
| Support Level | $12.52 | $10.17 |
| Resistance Level | $16.50 | $10.33 |
| Average True Range (ATR) | 1.84 | 0.01 |
| MACD | 0.31 | 0.00 |
| Stochastic Oscillator | 79.71 | 100.00 |
Iambic Therapeutics Inc is a technology and clinical-stage life sciences company developing novel medicines using its proprietary molecular superintelligence platform.
Drugs Made In America Acquisition II Corp is a blank check Company.